Verona Pharma PLC ADR (VRNA) Insider Trading
- $567,802.24
- $126,492,742.00
- May 29, 2025
- David Zaccardelli
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 1, 2023 | CFO | 105,944 | $2.68 | Sell | $283,929.92 | |
| Aug. 1, 2023 | Insider | 19,736 | $2.68 | Sell | $52,892.48 | |
| May 15, 2023 | Director | 359,713 | $20.08 | Sell | $7,223,037.04 | |
| May 11, 2023 | Director | 80,000 | $22.26 | Sell | $1,780,800.00 | |
| May 3, 2023 | Insider | 28,752 | $2.65 | Sell | $76,192.80 | |
| May 1, 2023 | CEO | 455,536 | $2.58 | Sell | $1,175,282.88 | |
| May 1, 2023 | General Counsel | 80,376 | $2.58 | Sell | $207,370.08 | |
| May 1, 2023 | CFO | 455,528 | $2.58 | Sell | $1,175,262.24 | |
| May 1, 2023 | Insider | 77,424 | $2.58 | Sell | $199,753.92 | |
| Feb. 1, 2023 | General Counsel | 152,000 | $2.59 | Sell | $393,680.00 | |
| Feb. 1, 2023 | CEO | 432,928 | $2.56 | Sell | $1,108,295.68 | |
| Feb. 1, 2023 | Insider | 89,960 | $2.56 | Sell | $230,297.60 | |
| Feb. 1, 2023 | CFO | 413,168 | $2.56 | Sell | $1,057,710.08 | |
| Dec. 22, 2022 | General Counsel | 240,000 | $2.69 | Sell | $645,600.00 | |
| Dec. 22, 2022 | Director | 3,969,496 | $21.77 | Sell | $86,415,927.92 | |
| Dec. 20, 2022 | CEO | 600,000 | $2.12 | Sell | $1,272,000.00 | |
| Aug. 9, 2022 | CEO | 600,000 | $1.75 | Sell | $1,050,000.00 | |
| Aug. 2, 2022 | Insider | 28,752 | $0.70 | Sell | $20,126.40 | |
| Aug. 1, 2022 | CFO | 13,168 | $0.70 | Sell | $9,217.60 | |
| Aug. 1, 2022 | CEO | 32,904 | $0.70 | Sell | $23,032.80 | |
| May 3, 2022 | Insider | 28,752 | $0.49 | Sell | $14,088.48 | |
| May 3, 2022 | CEO | 32,904 | $0.50 | Sell | $16,452.00 | |
| May 3, 2022 | CFO | 12,512 | $0.50 | Sell | $6,256.00 | |
| April 11, 2022 | Insider | 59,720 | $0.54 | Sell | $32,248.80 | |
| April 8, 2022 | Insider | 112,800 | $0.59 | Sell | $66,552.00 | |
| Feb. 3, 2022 | CEO | 52,056 | $0.73 | Sell | $38,000.88 | |
| Feb. 2, 2022 | CFO | 10,416 | $0.76 | Sell | $7,916.16 | |
| Feb. 1, 2022 | Director | 11,664 | $0.78 | Sell | $9,097.92 | |
| Nov. 2, 2021 | Director | 11,672 | $0.66 | Sell | $7,703.52 | |
| Nov. 2, 2021 | CFO | 10,416 | $0.65 | Sell | $6,770.40 | |
| Nov. 2, 2021 | CEO | 52,056 | $0.64 | Sell | $33,315.84 | |
| Aug. 3, 2021 | CEO | 16,000 | $0.76 | Sell | $12,160.00 | |
| Aug. 2, 2021 | CFO | 10,416 | $0.77 | Sell | $8,020.32 | |
| May 4, 2021 | Director | 12,056 | $0.84 | Sell | $10,127.04 | |
| March 1, 2021 | CFO | 26,728 | $1.14 | Sell | $30,469.92 | |
| March 1, 2021 | CEO | 43,392 | $1.14 | Sell | $49,466.88 | |
| Feb. 1, 2021 | Director | 10,800 | $0.99 | Sell | $10,692.00 |
Insiders are both buying and selling Verona Pharma PLC ADR stock.
The insider traders at Verona Pharma PLC ADR are: David Zaccardelli, Mark W Hahn, Kathleen A Rickard, Claire Poll, Orbimed Advisors Llc, Anders Ullman, David R Ebsworth, Lisa Deschamps, Mark W. Hahn, Martin Edwards, Andrew Fisher, and Vikas Sinha
The most active insider trader at Verona Pharma PLC ADR is David Zaccardelli with 29 trades.
Orbimed Advisors Llc has sold the most Verona Pharma PLC ADR stock with a total value of $102,642,802.00.
David R Ebsworth has bought the most Verona Pharma PLC ADR stock with a total value of $694,656.00.
The most recent insider trade for Verona Pharma PLC ADR was on May 29, 2025.
The single biggest insider buy for Verona Pharma PLC ADR was from David R Ebsworth with a total value of $316,800.00 on Nov. 6, 2023.
The single biggest insider sell for Verona Pharma PLC ADR was from Orbimed Advisors Llc with a total value of $86,415,927.92 on Dec. 22, 2022.